Novo Nordisk partners with Anthropic to use Claude in drug discovery and R&D

Novo Nordisk and Anthropic are teaming up to apply Anthropic's Claude across drug discovery, R&D and software engineering, aiming to speed biological research. Dario Amodei said the goal is to compress "a century's worth of biological and medical breakthroughs into a decade."

Detected & updated continuously · Source: Nebula

Story subjects

Novo-Nordisk A/SAnthropicClaudeDario Amodei

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula